Minaxi P. Jhawer, MD
- Hematology
- Oncology
I strongly believe empowering my patients and their family with the knowledge of their diagnosis and treatment options is integral to their care. I strive to personalize and individualize the treatment options for each patient.
Languages Spoken
- Gujrati
- Hindi
Related Services
Related Practices
Specialties, Procedures &
Conditions Treated
Primary Areas of Practice
- Hematology
- Oncology
Other Areas of Practice
- Bloodless Medicine
- Cancer Prevention
- Integrative Medicine
- Palliative Care
Procedures
- Bloodless Medicine & Surgery
- Cancer Pain Management
- Chemotherapy
- Immunotherapy
- Infusion Therapy
- Intrathecal Therapy
- Plasmapheresis and Exchange
- Targeted Therapy
Conditions Treated
- Anal Cancer
- Appendix Cancer
- Bile Duct Cancer
- Cholangiocarcinoma
- Colon Cancer
- Colorectal Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastroesophageal Junction (GEJ) Cancer
- Gastrointestinal Cancer
- Liver Cancer
- Pancreatic Cancer
- Peritoneal Cancer
- Peritoneal Surface Cancer
- Rectal Cancer
- Stomach Cancer
Locations &
Appointments
Locations
Hematology Oncology Physicians of Englewood - Englewood Health Physician Network
350 Engle Street 6th Floor, Berrie Center Englewood, NJ 07631
Appointments
Insurance
Insurances Accepted
Please contact your insurance company directly prior to receiving services or care to confirm your coverage. Although we have made every effort to ensure this list is accurate, only your health insurance plan can provide complete information regarding your coverage and potential out-of-pocket costs.
1199 (SEIU)
- 1199 (SEIU)
Aetna
- Aetna Assure Premier Plus
- Aetna Better Health of New Jersey
- Aetna CCN
- Aetna CoreSource
- Aetna Coventry
- Aetna FIDE-SNP
- Aetna HMO
- Aetna Medicare Managed Care
- Aetna POS
- Aetna PPO
- Aetna Whole Health HMO
- Aetna Whole Health PPO
- Medsolutions
- Meritan Health
AmeriHealth
- AmeriHealth Administrator
- AmeriHealth HMO
- AmeriHealth PPO
- Value Network (Exchange Plan)
APWU
- APWU Health Plan
Cigna
- Cigna HMO
- Cigna Medicare Advantage
- Cigna Open Access Plus
- Cigna PPO
- Cigna Supplemental
- Great-West Healthcare (GWH)
- Health Partners
Clover Health
- Clover Medicare Advantage
Consumer Health Network (CHN)
- CHN PPO
EmblemHealth
- EmblemHealth EPO
- EmblemHealth EPO2
- EmblemHealth FEHB
- EmblemHealth FEHBP
- EmblemHealth GHI CBP
- EmblemHealth GHI PPO
- EmblemHealth National
- EmblemHealth PPO1
- EmblemHealth PPO2
- EmblemHealth PPO3
- EmblemHealth Tri-State
- Vytra
Empire BCBS
- Blue Priority
- Direct HMO
- Direct PPO
- Empire BCBS EPO
- Empire BCBS GEPO
- Empire BCBS HealthPlus Gatekeeper (prefix VFG)
- Empire BCBS HealthPlus Gatekeeper (prefix VJD)
- Empire BCBS HMO
- Empire BCBS Indemnity
- Empire BCBS Medicare Advantage
- Empire BCBS Medicare Advantage Plus
- Empire BCBS POS
- Empire BCBS PPO
Empire Plan (NYSHIP)
- Empire Plan (NYSHIP)
Fidelis Care NJ
- Fidelis Care NJ Medicaid Managed Care
First Health
- First Health
Galaxy Health Network PPO
- Galaxy Health Network PPO
GEHA
- GEHA Health Plan
Horizon BCBS
- Federal Employee Program
- Horizon BCBS Braven Health
- Horizon BCBS EPO
- Horizon BCBS HMO
- Horizon BCBS Medicare Managed Care
- Horizon BCBS PPO
- NJ Carpenters Fund
- OMNIA Tier 1
- Traditional
Horizon NJ Health
- Horizon NJ Health Medicaid
- Horizon NJ TotalCare (D-SNP)
Humana
- Humana ChoiceCare Network PPO
- Humana ChoiceCare+ Network PPO
- Humana ChoicePOS
- Humana Gold Choice Network PFFS
- Humana Gold Choice Network PFFS 23
- Humana Gold Plus DE-SNP
- Humana Gold Plus HMO
- Humana Medicare (Employer PPO Plus)
- Humana Medicare PPO
- Humana Medicare PPO 2023
- Humana National Medicare HMO
- Humana National POS - Open Access
- Humana National POS - Open Access Plus
MagnaCare
- Local 825
- MagnaCare PPO
Mail Handlers
- Mail Handlers Benefit Plan (MHBP)
Medicaid
- Medicaid NJ
Medicare
- Medicare NJ
MultiPlan/PHCS
- Beech Street
- MultiPlan Humana
- MultiPlan Worker's Comp
- PHCS
- Pomco
MVP Health Care
- MVP Health Care PPO
NALC
- NALC Health Benefit Plan
Nippon Life Insurance Co of America
- Nippon Life Benefits
Oxford
- Freedom
- Garden State Network
- Liberty
- Metro
- Oxford Medicare
QualCare
- Choice Care
- HIP HMO
- HIP PPO
- HIP PRIME HMO
- HIP PRIME PPO
- Oscar
- QualCare EPO
- QualCare FEHB
- QualCare GHI PPO
- QualCare HMO
- QualCare Humana
- QualCare PPO
- QualCare Worker's Comp
Railroad Medicare
- Railroad Medicare NJ
Transparent Health Network
- Transparent Health Network
TRICARE (Humana Military)
- TRICARE (Humana Military)
TRICARE North Region
- CHAMPVA
- DVA
UMR
- UMR
United Healthcare Community and State
- Dual Complete
- UnitedHealthcare Community and State Medicaid (NJ FamilyCare)
- UnitedHealthcare Community and State Medicare
UnitedHealthcare
- AARP
- Commercial and Marketplace
- Compass Benefit (Exchange)
- Medica
- River Valley
- UnitedHealthcare EPO
- UnitedHealthcare HMO
- UnitedHealthcare POS
- UnitedHealthcare PPO
- UnitedHealthcare StudentResources
Wellcare NJ
- Wellcare NJ Ambetter
- Wellcare NJ Medicare Managed Care
Wellpoint
- Wellpoint Medicaid
- Wellpoint Medicare Advantage
About
About Minaxi Jhawer
Dr. Jhawer is chief of hematology/oncology. She is board certified in internal medicine, medical oncology, and hematology and specializes in cancers of the esophagus, stomach, small bowel, liver and bile ducts (hepatobiliary tract), pancreas, colon, and rectum. Dr. Jhawer completed postdoctoral fellowship training at Johns Hopkins University. After her residency and fellowship at Albert Einstein College of Medicine, she served on the gastrointestinal medical oncology faculty at Memorial Sloan Kettering Cancer Center. She developed and co-led EHMC's disease management team in gastroenterology and hepatobiliary cancer. She co-leads the multidisciplinary cancer conferences for patients diagnosed with GI cancer.
Dr. Jhawer collaborates with colleagues from New York City hospitals on caring for oncology patients and on clinical trials. She has been a principal investigator on many clinical trials and has presented her work at national conferences and been published in peer-reviewed journals. Dr. Jhawer is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Association for Cancer Research. She was recently appointed to the Clinical Practice Guidelines Committee of the American Society of Clinical Oncology. Dr. Jhawer is active in medical education and community outreach programs. She is involved in development of the survivorship plan, palliative care in the outpatient setting, and integrative medicine atEnglewood Health's Graf Center for Integrative Medicine.
Honors & Awards
2020, 2019, 2017: Bergen Magazine Top Doctors
2020-2016: Castle Connolly Top Doctors New York Metro Area
2019: Exceptional Women in Medicine
2019-2017: Jersey's Best: Top Doctors for Cancer
2019-2015: Jersey's Best Magazine Top Doctors
2018, 2017, 2015: New York Magazine Best Doctors
2018: New Jersey Monthly Magazine Top Doctor
2017: Americas Most Honored Top 1% Professionals
2015: Life and Living Show- Interview 5/20/15
2015: 201 Magazine Top Doctors-Top 20 People to Watch in Health Care
Professional Memberships
American Society of Clinical Oncology
American Society of Hematology
American Medical Association
American Association for Cancer Research
Bergen Indian Medical Association
Committees and Leadership Positions
Chief, Hematology/Oncology
2017 - 2020: Member, American Society of Clinical Oncology Clinical Practice Guidelines Committee
2017: Elected to Medical Executive Committee
2016 - present: Bylaws Committee
2014 - present: Advisory Board for Integrative Medicine Department
2014 - present: Medical Advisory Board for Kula for Karma
Co-Leader for Upper, Lower GI and Hepatobiliary Tumor Board and DMT
Established Funding for Complementary Yoga Program for Englewood Hospital Cancer Patients and Their Caregivers
Survivorship Program for Patients with Curable Cancers
Established Pain and Palliative Consultation and Care in the Outpatient Oncology Setting
Global Health and Community Health Activities
Korean /Asian population screening for GI cancers
Education &
Training
Education & Degrees
MD: Dr. D.Y. Patil Medical College
Residency
Albert Einstein College of Medicine - Jacobi Medical Center
Fellowship
Montefiore Hospital and Medical Center
Certifications & Distinctions
- Hematology (American Board of Internal Medicine)
- Medical Oncology (American Board of Internal Medicine)
Publications
Publications
Klute KA, Brouwer J, Jhawer M, et al. Chemotherapy dose intensity predicted by baseline nutrition assessment in gastrointestinal malignancies: A multicenter analysis. Eur J Cancer. 2016 Aug;63:189-200
Shah MA, Jhawer M, Ilson D, Lekowitz RA et al. Phase II study of modified docetaxel, cisplatin,and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma. J Clin Oncol 2011 Mar 1;29(7):868-74
Wilson AK, Cheuh AC, Togel L, Corner GA, Ahmed N, Goel S, Byun DS, Nasser S, Houston MA, Jhawer M et al. Apoptotic sensitivity of colon cancer cell lines to histone deacetylase inhibitors is mediated by sp1/sp3 activated transcriptional program involving immediate early gene induction. Cancer Res 2010 Jan 15; 70(2):609-20
Yuan Z, Shin J, Wilson A, Goel S, Ahmed N, Dopeso H, Jhawer M, et al. An A13 repeat within the 3-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression. Cancer Res 2009 Oct 1;69(19):7811-8
Jhawer M, Coit D, Brennan M, Qin L, Gonen M, Klimstra D, Tang L, Kelsen D, Shah MA. Perineural invasion following preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation. Am J Clin Oncol. 2009 Aug;32(4):356-62
Jhawer M, Goel S, Wilson AJ, Montagna C, Ling YH et al. PIK3CA mutation/ PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. Cancer Res.2008 Mar 15;68(6):1953-61
Jhawer M, Kelsen D, Shah M. Incorporation of biologic therapies in the management of gastroesophageal cancers. Gastrointest Cancer Res. 2007 Mar; 1(2 suppl): S22-9
Jhawer M, Rosen L, Dancey J, Hochster H, Hamburg S, Tempero M, et al. Phase II Trial of Nolatrexed Dihydrochloride [ThymitaqTM, AG 337] in Patients with Advanced Hepatocellular Carcinoma. Investigational New Drugs 2007 Feb 25(1):85-94
Jhawer M, Mani S, Lefkopoulou M, Hahn R, Harris J, et al. Phase II study of Mitomycin-C, Adriamycin, Cisplatin and Bleomycin-CCNU in patients with advanced anal canal cancer: An ECOG study, E 7282. Investigational New Drugs 2006 Sep; 24(5):447-54
Goel S, Jhawer M, Sparano J, Mani S, et al Phase I clinical trial of the combination of irinotecan and oral capecitabine in patients with solid malignancies. Am J Clin Oncol. 2002 Oct; 25(5):528-34
For a full listing of Dr. Jhawer's publications, please visit PubMed.gov
Reviews & Ratings
Reviews & Ratings
Reviews and ratings on our website are based on feedback from verified patients collected by Press Ganey, an independent organization that surveys patients about their care experience.
| Provider showed concern |
|
| Provider explained things clearly |
|
| Provider included you in decisions |
|
| Provider discussed treatment options |
|
| Likelihood of recommending this provider |
|
Recent Comments
"I always find in my experienc with Dr Jhwar to be positive. Her kindness,is only surpassed by her competence."
"This is my first visit and everything is a good experience"
"As usual, quick, friendly and professionell"
"Always answers my questions and concerns"
"All good ."
"Good"
"All very well."
"Everything is very good"
"They listen and explain everything in simple terms"
"Very good, always, thank you"